Well, without a doubt now, that first patient dosing must have...

Well, without a doubt now, that first patient dosing must have demonstrated safety and tolerability. Otherwise, the FDA would not have allowed this to proceed. So first immediate hurdle done. Now, just need to see if such safety and tolerability would persist with bigger number.

Meanwhile, as long as that first patient is still alive, it is good news. It has been more than 6 weeks after her first dosing. By now, she would have a total of 3 doses. Seriously, if it is going to work, there would be some positive progress already in the first patient. Let's hope for a very positive update on her when the first preliminary report comes out.